Xiao-Mei Chen Hui Li Yu Wu Lan-Lan Wang Yang-Juan Bai Yun-Ying Shi
10.3389/fimmu.2022.1049444
Front Immunol
2022 Nov 29;13:1049444.
anti-erythropoietin (anti-epo) antibody immunosuppressive therapy kidney transplant pure red cell aplasia roxadustat
CC BY
https://pubmed.ncbi.nlm.nih.gov/36524109/
Kidney Transplantation / adverse effects Red-Cell Aplasia, Pure / drug therapy Red-Cell Aplasia, Pure / etiology
Kidney Transplantation / adverse effects Red-Cell Aplasia, Pure / drug therapy Red-Cell Aplasia, Pure / etiology Case Reports Research Support, Non-U.S. Gov't Antibodies Cyclosporine / therapeutic use Humans Immunosuppressive Agents / therapeutic use Male Prednisone / therapeutic use Recombinant Proteins / therapeutic use Sirolimus / therapeutic use Prednisone Antibodies Immunosuppressive Agents Recombinant Proteins Cyclosporine Sirolimus
PMC9744924
36524109
Case report: Dynamic antibody monitoring in a case of anti-recombinant human erythropoietin-mediated pure red cell aplasia with prolonged course after kidney transplantation
2022